Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT

Universitair Ziekenhuis Brussel

Status: Enrolling

Conditions: Neuromuscular Manifestations

Treatments: Device: EMG TOF device

Study type: Interventional

Funder types: Other

Identifiers

NCT04931901

StimpodVSDatex-Ohmeda

Details and patient eligibility

About

After anesthesia is induced, 2 EMG TOFF devices will be placed on the patients arms, one on the right arm, the other on the left. There will be a randomization per dominant hand and nondominant hand for the placing of the devices. The devices are the Stimpod NMX450X and the Datex-Ohmeda E-NMT.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients (18 years old and above)
• undergoing General Anaesthesia for noncardiac surgery requiring the use of a neuromuscular blocking agent.

Exclusion criteria

• Use of different types of neuromuscular blocking agents for the same patient within the same surgical procedure.
• Known Neuromuscular diseases/syndromes judged to condition accurate neuromuscular monitoring.
• Known acute or chronic hepatic disease.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

Stimpod NMX450X

Experimental group

Treatment:

Device: EMG TOF device

Datex-Ohmeda E-NMT

Active Comparator group

Treatment:

Device: EMG TOF device